Skip to Content

CSPC Pharmaceutical Group Ltd CHJTF

Rating as of

Morningstar’s Analysis

Valuation
Currency in USD
Is it the right time to buy or sell?
Find out with Morningstar Premium
Is it the right time to buy or sell?
Find out with Morningstar Premium

1-Star Price

PREMIUM

5-Star Price

PREMIUM

Economic Moat

PREMIUM

About Quantitative Ratings

Morningstar Quantitative ratings for equities (denoted on this page by) are generated using an algorithm that compares companies that are not under analyst coverage to peer companies that do receive analyst-driven ratings. Companies withratings are not formally covered by a Morningstar analyst, but are statistically matched to analyst-rated companies, allowing our models to calculate a quantitative moat, fair value, and uncertainty rating. Click here for more on how to use these ratings.

Company Profile

Business Description

CSPC Pharmaceutical Group Ltd., or CSPC, is one of the largest drug manufacturers in China. The company has a diversified portfolio that includes innovative drugs, common generic drugs, and bulk drugs. Its R&D pipeline is primarily focused on cardio-cerebrovascular diseases, digestion and metabolic diseases, oncology, neurology, and anti-infectives.

Contact
No. 226 Huanghe Street, Hebei Province
Shijiazhuang, 050035, Hong Kong
T +86 31187037015
Sector Healthcare
Industry Drug Manufacturers - General
Most Recent Earnings
Fiscal Year End Dec 31, 2020
Stock Type
Employees 17,292